Omnia Biologics , Inc.

aav bl-2 bl-3 bl2 bl3 bsl-2 bsl-3 biologics biotechnology cmo gmp phase i phase ii vlp adeno adenovirus aseptic filling aseptic finish/fill biodefense cgmp cell therapy clinical materials clinical trial material contract manufacturing gene therapy lenti lentivirus master cell bank pre-clinical preclinical process development retrovirus tox material vaccine vaccine production virus virus bank virus seed stock working cell bank Show more